Couldn’t attend the International Stroke Conference (6–8 February 2019, Honolulu, HI, USA)? Find out more about the key headlines here.
Couldn’t attend the 143rd Annual Meeting of the American Neurological Association? Discover more about the key highlights here.
More evidence reported for causal link between herpes viruses and Alzheimer’s; reinvigorating research into the possible role of infections – and their treatment – in the disease.
A recent study indicates that a chronic periodontal pathogen infection could result in the development of Alzheimer’s disease.
New research by NIH-funded scientists has revealed evidence that viral species, particularly herpesviruses, could contribute toward the complex biology underlying Alzheimer’s disease.
Whilst at SfN’s Neuroscience 2017, Lauren Pulling sat down with Kijun Yoon, who discussed the latest updates in Zika research, including his work on a Zika virus protein that may cause microcephaly.
Is a Zika vaccine imminent? Martha Powell provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
How researchers and physicians have risen to the Zika challenge a short year and half after the WHO declared a public health emergency.
NCTalks at AAN 2017: Michael Pender on a new multiple sclerosis treatment targeting Epstein-Barr virus
Michael Pender discusses promising interim findings from a Phase 1 study investigating a novel treatment for multiple sclerosis.
In new research, the first live-attenuated Zika vaccine has been demonstrated to protected mice against the virus after a single dose.